DGN-Leitlinie Diagnostik und Therapie der Multiplen Sklerose: Was gibt es Neues - Ergänzung 2014

R. Gold; H. Wiendl; B. Hemmer

doi:10.1055/s-0034-1370162

DGN-Leitlinie Diagnostik und Therapie der Multiplen Sklerose: Was gibt es Neues - Ergänzung 2014

Translated title of the contribution: DGN guidelines diagnosis and treatment of multiple sclerosis: Update 2014

R. Gold
, H. Wiendl
, B. Hemmer

Default

Huntington-Zentrum (NRW) Bochum im St. Josef Hospital
University of Münster

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Abstract

Treatment of relapsing MS has been greatly improved by the recent approval of novel immunotherapies. Yet there is still no clear pathway for individualized therapy. Also no head-to-head studies are available. On this background the updated DGN-guidelines for diagnosis and treatment of MS give expert recommendations.

Translated title of the contribution	DGN guidelines diagnosis and treatment of multiple sclerosis: Update 2014
Original language	German
Pages (from-to)	326-327
Number of pages	2
Journal	Aktuelle Neurologie
Volume	41
Issue number	6
DOIs	https://doi.org/10.1055/s-0034-1370162
State	Published - Jul 2014

Access to Document

10.1055/s-0034-1370162

Cite this

@article{b3ae6b69d17f40358ab824d19df15f13,

title = "DGN-Leitlinie Diagnostik und Therapie der Multiplen Sklerose: Was gibt es Neues - Erg{\"a}nzung 2014",

abstract = "Treatment of relapsing MS has been greatly improved by the recent approval of novel immunotherapies. Yet there is still no clear pathway for individualized therapy. Also no head-to-head studies are available. On this background the updated DGN-guidelines for diagnosis and treatment of MS give expert recommendations.",

keywords = "expert recommendation, immune therapy, multiple sclerosis",

author = "R. Gold and H. Wiendl and B. Hemmer",

year = "2014",

month = jul,

doi = "10.1055/s-0034-1370162",

language = "Deutsch",

volume = "41",

pages = "326--327",

journal = "Aktuelle Neurologie",

issn = "0302-4350",

publisher = "Georg Thieme Verlag",

number = "6",

}

TY - JOUR

T1 - DGN-Leitlinie Diagnostik und Therapie der Multiplen Sklerose

T2 - Was gibt es Neues - Ergänzung 2014

AU - Gold, R.

AU - Wiendl, H.

AU - Hemmer, B.

PY - 2014/7

Y1 - 2014/7

N2 - Treatment of relapsing MS has been greatly improved by the recent approval of novel immunotherapies. Yet there is still no clear pathway for individualized therapy. Also no head-to-head studies are available. On this background the updated DGN-guidelines for diagnosis and treatment of MS give expert recommendations.

AB - Treatment of relapsing MS has been greatly improved by the recent approval of novel immunotherapies. Yet there is still no clear pathway for individualized therapy. Also no head-to-head studies are available. On this background the updated DGN-guidelines for diagnosis and treatment of MS give expert recommendations.

KW - expert recommendation

KW - immune therapy

KW - multiple sclerosis

UR - https://www.scopus.com/pages/publications/84904752335

U2 - 10.1055/s-0034-1370162

DO - 10.1055/s-0034-1370162

M3 - Artikel

AN - SCOPUS:84904752335

SN - 0302-4350

VL - 41

SP - 326

EP - 327

JO - Aktuelle Neurologie

JF - Aktuelle Neurologie

IS - 6

ER -

DGN-Leitlinie Diagnostik und Therapie der Multiplen Sklerose: Was gibt es Neues - Ergänzung 2014

Abstract

Access to Document

Other files and links

Fingerprint

Cite this